带有TDP-43型C病理的前叶退化的转录学签名
Ana Rajicic1, Merel O Mol2, Shamiram Melhem1
1Department of Neurology and Alzheimer Centre Erasmus MC, Erasmus University Medical Centre, 3015 GD Rotterdam, The Netherlands.
Brain : a journal of neurology
|March 6, 2026
概括
语义变体初级渐进性失言症 (svPPA) 涉及TDP-43病理. 这项研究发现,皮层中下调的突触过程和上调的细胞结构/RNA拼接,为svPPA提供了洞察力.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 病理学 病理学 病理学
背景情况:
- 语义变体初级渐进性失语症 (svPPA) 是一种前叶退化亚型,其特征是TDP-43 C病理 (FTLD-TDP C).
- 尽管呈现均,但其潜在的病理生理学需要进一步阐明.
- 皮质是FTLD-TDP C.中受影响最严重的区域.
研究的目的:
- 通过转录学识别FTLD-TDP C患者的皮质中失调的分子通路.
- 研究TARDBP (TAR DNA结合蛋白) 在FTLD-TDP C病原发生中的作用.
- 区分FTLD-TDPC特异性分子变化与其他神经退行性疾病中常见的分子变化.
主要方法:
- 从18名FTLD-TDP C患者和23名对照患者的皮组织中进行大量RNA测序.
- 差异基因表达分析 (FDR<0.05),功能注释 (SynGO) 和权重基因共同表达网络分析 (WGCNA).
- 细胞类型解和与病症和其他FTLD-TDP亚型的现有数据集进行比较.
主要成果:
- 鉴定了6322个差异表达基因 (DEG) 和五个与疾病相关的WGCNA模块.
- 发现对损伤反应,细胞结构和RNA剪接的上调,以及对突触过程的下调.
- 在DEG中丰富了与TARDBP相关的基因,并证实了细胞类型和病基因正常化后的突触后过程的失调.
结论:
- FTLD-TDP C表现出广泛的转录基因失调,包括细胞结构变化和RNA拼接变化.
- 后突触过程的下调,特别是受体组合和突触传播,是FTLD-TDP C在RNA和蛋白质水平的关键特征.
- 十一个特定的突触基因 (例如CADM1,NCAN,COMT) 涉及到FTLD-TDP C病原体,提供潜在的治疗标.
相关概念视频
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...